Sign in by typing your Id and password
Settings
Help
Organizations >
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. P11DC-THERA Partner |
Argos Therapeutics, Inc. is developing breakthrough immunotherapies that target unique features of a patient’s disease. This new generation of personalized cancer and infectious disease therapeutics trains the immune system to recognize and attack the disease. Argos’ scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform to tackle virtually all forms of cancers and infectious diseases.
Argos, a private biotechnology company, is headquartered in Research Triangle Park, NC. The Company has clinical trial programs in cancer and human immunodeficiency virus (HIV) and has an ongoing co-development and commercialization alliance with the Pharmaceutical Division of Kirin Brewery Company, Limited.
Argos, a private biotechnology company, is headquartered in Research Triangle Park, NC. The Company has clinical trial programs in cancer and human immunodeficiency virus (HIV) and has an ongoing co-development and commercialization alliance with the Pharmaceutical Division of Kirin Brewery Company, Limited.
Affiliated Persons
|
|
Scientific responsible
|
Contact Information
| Phone |
+1 (919) 287-6300 | |
| Web |
http://www.argostherapeutics.com/ | |
| Address |
4233 Technology Drive
Durham (North Carolina) USA |
|
]